Objective:To observe the clinical efficacy and safety of BuShenHuoXue treatment for primary osteoporosis.Method:The observed cases were randomly divided into two groups,the experimental group and the control group,280 cases in each group.Experimental group patients were given BuShenHuoXue treatment,The control group patients were given the Xianlinggubao capsule.Bone mineral density in the two groups was observed after 6 months of treatment,and at the same time,urine,stool test,liver function,renal function and blood sugar changes were observed and recorded. Result:The clinical efficacy of the experimental group was better than that of the control group(P<0.05).Before treatment,liver and kidney function and blood sugar check of the 280 patients in the experimental group showed no abnormality,after treatment,liver and kidney function and blood sugar were normal.Before and after treatment,the patients had no other adverse reactions.Conclusion:BuShenHuoXue treatment is effective for primary osteoporosis, its efficacy is superior to Xianlinggubao capsules,and there is no adverse reactions.% 目的：观察补肾活血方治疗原发性骨质疏松症的临床疗效和安全性.方法：将所观察的病例随机分为实验组和对照组,每组280例.实验组患者采用补肾活血方治疗,对照组患者口服仙灵骨葆胶囊,治疗6个月后观察两组骨密度变化,同时观察记录两组尿、大便常规,肝肾功能的改变情况.结果：实验组临床疗效优于对照组(Z=-8.885,P=0.000).治疗前对实验组280例患者进行了肝肾功能及血糖检查均无异常,治疗后进行了复查,肝肾功能及血糖均正常.治疗前后患者亦未发现其他不良反应.结论：补肾活血方能有效治疗原发性骨质疏松症,其疗效优于仙灵骨葆胶囊,且无不良反应.
展开▼
